Alterations in Coxsackievirus B4 Heart Muscle Disease in ICR Swiss Mice by Anti-thymocyte Serum Free

Abstract

SUMMARY

Coxsackievirus B4 (CB4) infection in infant ICR Swiss mice induces synchronous peaks in both virus titres and pathologic changes in the heart. Among surviving mice, transmural necrosis is followed by fibrosis and ventricular aneurysm. Rabbit anti-mouse thymocyte serum (ATS) was given before CB4 infection to determine the effects of thymus-dependent functions upon the course of disease. The mortality in ATS-treated mice was 75.9% (65 of 83 mice died) compared to 21.3% (16 of 75 mice died) in normal rabbit serum-treated controls. Pathologic studies showed that ATS-treated mice had more extensive myofibre necrosis and subsequent mineralization, but during the first 10 days of infection, leukocytic infiltration was decreased. Splenic follicles were not present until the 17th day after infection in this treated group. Serum CB4-neutralizing antibodies were similar in mice from the group treated with ATS and normal rabbit serum. These findings indicate that ATS-suppressible functions contribute importantly to virus elimination, perhaps by an increase in macrophage phagocytosis of CB4.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-1-231
1983-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/1/JV0640010231.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-1-231&mimeType=html&fmt=ahah

References

  1. Khatib R., Chason I. L., Silberberg B. K., Lerner A. M. 1980; Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. Journal of Infectious Diseases 141:394–403
    [Google Scholar]
  2. Khatib R., Chason I. L., Lerner A. M. 1982; A mouse model of transmural myocardial necrosis due to coxsackievirus B4: observations over twelve months. Intervirology (in press)
    [Google Scholar]
  3. Loria R. M., Kilbrick S., Madge G. E. 1976; Infection of hypercholesterolemic mice with coxsackievirus B. Journal of Infectious Diseases 133:655–662
    [Google Scholar]
  4. Rager-zisman B., Allison A. C. 1973a; The role of antibody and host cells in the resistance of mice against infection by coxsackie B3 virus. Journal of General Virology 19:329–338
    [Google Scholar]
  5. Rager-zisman B., Allison A. C. 1973b; Effects of immunosuppression on coxsackie B3 virus infection in mice and passive protection by circulating antibody. Journal of General Virology 19:339–351
    [Google Scholar]
  6. Schuit K. E., Powell D. A. 1980; Phagocytic dysfunction in monocytes of normal newborn infants. Pediatrics 65:501–504
    [Google Scholar]
  7. Wilson F. M., Miranda Q. R., Chason J. L., Lerner A. M. 1969; Residual pathologic changes following murine coxsackie A and B myocarditis. American Journal of Pathology 55:253–265
    [Google Scholar]
  8. Wong C. Y., Woodruff J. J., Woodruff I. F. 1977a; Generation of cytotoxic T-lymphocytes during coxsackievirus B3 infection. I. Model and viral specificity. Journal of Immunology 118:1159–1164
    [Google Scholar]
  9. Wong C. Y., Woodruff J. J., Woodruff J. F. 1977b; Generation of cytotoxic T-lymphocytes during coxsackievirus B3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral infected myofibers. Journal of Immunology 118:1165–1169
    [Google Scholar]
  10. Woodruff J. F., Woodruff J. J. 1974; Involvement of T-lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. Journal of Immunology 113:1726–1734
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-1-231
Loading
/content/journal/jgv/10.1099/0022-1317-64-1-231
Loading

Data & Media loading...

Most cited Most Cited RSS feed